Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
PharmAbcine Inc.
Scientific Title
A Phase 1b, Open-Label, Safety and Tolerability Study of TTAC-0001 in Combination With Pembrolizumab in Patients With Recurrent Glioblastoma